课题基金 / 基金详情

The Biological Role of SCC Antigen in Head and Neck Cancer

The Biological Role of SCC Antigen in Head and Neck Cancer
SCC 抗原在头颈癌中的生物学作用
批准号:
15591820
负责人:
NAKASHIMA Torahiko
金额:
$1.98万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

NAKASHIMA Torahiko的其他基金

相似基金

相关文献

中文摘要
翻译
丝氨酸蛋白酶在肿瘤的侵袭和转移过程中起重要作用,其抑制剂丝氨酸蛋白酶抑制剂(sereproteinhibitors,serpins)是一种极具吸引力的治疗靶点。在染色体18 q21上,有一簇丝氨酸蛋白酶抑制剂; maspin,headpin和SCCA 1。其他人和我们已经报道,与正常鳞状上皮细胞相比,这些丝氨酸蛋白酶抑制剂的表达在HNSCC细胞中下调。我们假设SCCA 1的表达对HNSCC细胞在生物学上是不利的。与载体对照相比,用具有SCCA 1 cDNA的哺乳动物表达载体稳定转染的已建立的HNSCC细胞系的体外和体内侵袭被显著抑制。SCCA 1可能具有抑制HNSCC侵袭的作用。我们还报道了血清SCC抗原水平与鼻窦内翻性乳头状瘤(IP)的疾病状态相关,并有可能作为监测疾病过程的有用工具。SCC抗原是治疗鼻腔鼻窦IP的可靠肿瘤标志物。
英文摘要
Serine proteases have important roles in tumor invasion and metastasis and their inhibitors, serine protease inhibitors (serpins) are attractive targets for therapeutic strategies. On chromosome 18q21,there is a cluster of serpins ; maspin, headpin, and SCCA1. Others and we have reported that the expression of these serpins are down-regulated in HNSCC cells as compared to normal squamous epithelial cells. We have hypothesized that expression of SCCA1 is biologically disadvantageous to HNSCC cells. The in vitro and in vivo invasion of established HNSCC cell lines stably transfected with a mammalian expression vector with SCCA1 cDNA was significantly inhibited compared to the vector control. SCCA1 may function to inhibit the invasive potential of HNSCC.We also reported that Serum SCC antigen level has a correlation with disease status of sinonasal inverted papilloma(IP) and has a potential to serve as a useful tool for monitoring the course of disease. SCC antigen is a reliable tumor marker in the management ofsinonasal IPs.
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
Yasumatsu R, Kuratomi Y, Nakashima T, et al.: "Cyclin D1 expression does not effect cell proliferation in adenoid cystic carcinoma of the salivary gland"Eru Arch Otorhinolaryngol.. (印刷中). (2004)
Yasumatsu R、Kuratomi Y、Nakashima T 等人:“细胞周期蛋白 D1 表达不会影响唾液腺腺样囊性癌中的细胞增殖”Eru Arch Otorhinolaryngol..(出版中)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
The effect of cyclin D1 overexpression in human head and neck cancer cells.
细胞周期蛋白 D1 过度表达对人头颈癌细胞的影响。
DOI: --
发表时间: 2004
期刊: Eur.Arch Otorhinolaryngol Epub ahead of print)
影响因子: --
作者: [Nakashima T, Yasumatsu R et al.]
通讯作者: Yasumatsu R et al.
Effect of the angiotensin-1 converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells.
血管紧张素1转换酶抑制剂培哚普利对头颈鳞状细胞癌细胞肿瘤生长和血管生成的影响。
DOI: --
发表时间: 2004
期刊: J Cancer Res Clin Oncol 130・10
影响因子: --
作者: [Yasumatsu R, Nakashima T, et al.]
通讯作者: et al.
鼻副鼻腔内反性乳頭腫における血清SCC抗原測定の意義
鼻窦睑内翻乳头状瘤血清SCC抗原测定的意义
DOI: --
发表时间: 2004
期刊: 日鼻誌 43・1
影响因子: --
作者: [安松隆治, 中島寅彦他]
通讯作者: 中島寅彦他
共 10 条
    Chemoprevention of Head and neck Cancer utilizing an animal model
    • 批准号:
      23592531
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2011
    • 负责人:
      NAKASHIMA Torahiko
    • 依托单位:
    The role of Thymidylate Synthase (TS) and Dihydropyrimidine Dehydrogenase (DPD)expression in 5-FU based chemoradiation for head and neck cancer
    • 批准号:
      20592021
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2008
    • 负责人:
      NAKASHIMA Torahiko
    • 依托单位:
    The Molecular Mechanism of SCC Antigen Expression in Head and Neck Cancer
    • 批准号:
      17591793
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.11万
    • 财政年份:
      2005
    • 负责人:
      NAKASHIMA Torahiko
    • 依托单位:
    The Biological Role of Headpin in Head and Neck Cancer
    • 批准号:
      13671786
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2001
    • 负责人:
      NAKASHIMA Torahiko
    • 依托单位:
    海外基金